ICS 2023 Scientific Podium Short Oral Session S6 - Overactive Bladder and Neuromodulation

ICS Members Only

Become an ICS Member today to watch

Join ICS Sign in

{{CC.VideoPaywalButtonText}} Sign in Sign in

Restricted Video

Sign in to watch

You do not have permission to view this video

ICS members can access all the meeting webcasts

Sign in Join Now

ICS Members Only Restricted Video

Speakers
	Scientific Podium Short Oral Session S6
	Wednesday 27th September 2023
	14:00 - 15:30
	Theatre 102 Capacity: 1200
	Lunch provided
	Recorded for Gold Pass attendees Find out more
D Desiree Vrijens ICS Chair H Hashim Hashim ICS Chair
Professional interest
Urology

14:00

#25 CLINICAL EFFICACY OF NEUROMODULATION ON TREATMENT OF OVERACTIVE BLADDER IN MULTIPLE SCLEROSIS: A SYSTEMATIC REVIEW

Presenter: Yat Ching Fung

Fung Y¹, Huaman M², Garcia D³, Blaivas J²
1. St George's University, 2. Institute for Bladder and Prostate Research, 3. SUNY Downstate Health Sciences University
Multiple Sclerosis, Neuromodulation, Overactive Bladder

14:07

#26 First clinical results of UCon neurostimulator on Dorsal Genital Nerve stimulation in patients with OAB

Presenter: Niels Klarskov

Klarskov N¹, El Issaoui M², Glavind-Kristensen M³, Graugaard-Jensen C⁴, Qvist N⁵, Rijkhoff N⁵, Duelund-Jakobsen J⁶, Christensen P⁷
1. Dept. of Obstetrics and Gynecology, Herlev and Gentofte Hospital, 2. Dept. of Obstetrics and Gynecology, Herlev and Gentofte University Hospital, 3. Dept. of Obstetrics and Gynecology, Aarhus University Hospital, 4. Dept. of Urology, Aarhus University Hospital, 5. Dept of Surgery Odense University Hospital, 6. Dept of Surgery Aarhus Universitetshospital, 7. Pelvic Floor Unit Dept of Surgery Aarhus University Hospital
Overactive Bladder, Neuromodulation, New Instrumentation, Urgency Urinary Incontinence, Urgency/Frequency

14:15

#27 WOULD MEDIUM FREQUENCY ELECTROSTIMULATION BE AS GOOD AS TENS FOR THE TREATMENT OF WOMEN WITH OVERACTIVE BLADDER? PRELIMINARY RESULTS OF A RANDOMIZED CLINICAL TRIAL

Presenter: Patricia Lordelo

Caetano S¹, Teles A², Brasil C³, Lemos A³, Queiroz Vilas Boas A¹, Almeida A¹, Oliveira dos Santos C⁴, Sodré D², Santana L¹, Piason L¹, Cerqueira M², Pavie M⁵, Ferreira M¹, Godoy Januário P⁶, Gomes T⁵, Cardoso R⁷, Vieira M¹, Sevani Maggitti de Souza V¹, Lopes M¹, Carvalho G⁸, Bacelar J², Alves I², Dourado N⁹, Lordelo P¹⁰
1. Escola Bahiana de Medicina e Saúde Pública - EBMSP; Instituto Patricia Lordelo - IPL, 2. Instituto Patricia Lordelo - IPL, 3. Escola Bahiana de Medicina e Saúde Pública - EBMSP; Instituto Patricia Lordelo - IPL; UNIME, 4. Universidade do Estado da Bahia - UNEB; Instituto Patricia Lordelo - IPL; Escola Bahiana de Medicina e Saúde Pública, 5. Escola Bahiana de Medicina e Saúde Pública - EBMSP; Instituto Patricia Lordelo - IPL; Universidade Salvador - UNIFACS, 6. Universidade do Estado da Bahia - UNEB; Instituto Patricia Lordelo - IPL, 7. Instituto Patricia Lordelo - IPL; UniDomPedro, 8. Universidade Salvador - UNIFACS; Instituto Patricia Lordelo - IPL, 9. Centro Universitário UniFTC Salvador; Instituto Patrícia Lordelo - IPL, 10. Escola Bahiana de Medicina e Saúde Pública; Instituto Patricia Lordelo - IPL
Urgency Urinary Incontinence, Incontinence, Conservative Treatment, Mixed Urinary Incontinence

14:22

#28 ASSESSING FACTORS IN PATIENT DECISION BETWEEN RECHARGEABLE AND NON-RECHARGEABLE SACRAL NEUROSTIMULATORS IN TREATMENT OF VOIDING DYSFUNCTION

Presenter: William Stallings

Stallings W¹, Wang A¹, Rovner E¹
1. MUSC
Neuromodulation, Overactive Bladder, Voiding Dysfunction

14:30

#29 Usefulness of a NESA®, a new non-invasive neuromodulation system, in the treatment of overactive bladder syndrome

Presenter: Guillermo Conde Santos

Conde Santos G¹, Martín Martínez A², Carballo Rastrilla S², Fernandez Mederos A², Medina Ramírez R³, Quintana Montesdeoca M⁴
1. Department of Urology, Hospital Quironsalud Tenerife, Universidad Europea de Canarias, 2. Department of Gynecologist and Obstetrician, Complejo Hospitalario Universitario Insular Materno Infantil Las Palmas de Gran Canaria, 3. Laboratory of phisiotherapy and Electrofisiology. Universidad de Las Palmas de Gran Canaria, 4. Departamento de Matemáticas. Universidad de Las Palmas de Gran Canaria
Overactive Bladder, New Devices, Prospective Study, Neuromodulation, Female

14:37

#30 Shifts in Patient Preference of Third-Line Overactive Bladder Therapy After Introduction of the Implantable Tibial Nerve Stimulator

Presenter: Arshia Aalami Harandi

Kapur A¹, Aalami Harandi A¹, Kim J¹
1. Stony Brook Urology
Urgency/Frequency, Overactive Bladder, Urgency Urinary Incontinence, New Devices, Neuromodulation

14:45

#31 Posterior Tibial Nerve Stimulation With versus Without Mirabegron in Women with Refractory UUI and OAB-wet: A Randomized Controlled Trial

Presenter: Russell Stanley

Stanley R¹, Richter H¹, Meyer I¹, Blanchard C¹
1. University of Alabama at Birmingham
Overactive Bladder, Urgency/Frequency, Voiding Diary, Incontinence, Clinical Trial

14:52

#32 3-Month Interim Results of a Phase 4, Real-World Study (COMPOSUR) to Evaluate Vibegron in Patients With Overactive Bladder

Presenter: Scott A MacDiarmid

MacDiarmid S¹, Dmochowski R², Rovner E³, Kennelly M⁴, Newman D⁵, Abedinzadeh L⁶, Snyder D⁶, Thomas E⁶
1. Alliance Urology Specialists, 2. Vanderbilt University Medical Center, 3. Medical University of South Carolina, 4. Carolinas Medical Center, 5. Perelman School of Medicine, University of Pennsylvania, 6. Urovant Sciences
Clinical Trial, Overactive Bladder, Urgency Urinary Incontinence, Urgency/Frequency

15:00

#33 A Randomized Placebo Controlled Trial of Mirabegron on Alleviating Stent-Related Symptoms among Patients with Indwelling Double J Stent

Presenter: Mookdarat Siantong

Sirisreetreerux P¹, Siantong M¹, Pattanaprateep O¹
1. Faculty of Medicine Ramathibodi hospital, Mahidol University
Female, Quality of Life (QoL), Clinical Trial, Pharmacology, Urgency/Frequency

15:07

#34 Reported desire to void shows a direct relationship with voided volumes in healthy adults, but not in OAB patients

Presenter: Martijn Smits

Klijnsma A¹, Smits M², van Koeveringe G², de Rijk M¹
1. Department of Urology, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Science, Maastricht University, The Netherlands, 2. Department of Urology, Maastricht University Medical Center+, The Netherlands
Female, Overactive Bladder, Questionnaire, Urgency/Frequency, Voiding Diary

15:15

#36 Use of the oral sialogogue “Oryza tablet” in reducing drug-induced xerostomia in patients with overactive bladder or neurogenic bladder: randomized clinical study

Presenter: Surawach Piyawannarat

Viseshsindh W¹, Tancharoen S¹, Sirisreetreerux P¹, Rattanapornsompong W¹, Somboonpun K¹, Piyawannarat S¹
1. Mahidol university
Pharmacology, Overactive Bladder, Quality of Life (QoL), Prospective Study

15:22

#35 Progression of overactive bladder symptoms in patients with prior SARS-CoV-2 infection

Presenter: Priya Padmanabhan

Padmanabhan P¹, Zwaans B¹, Hoang-Roberts L²
1. Corewell Health William Beaumont University Hospital, 2. Cleveland Clinic
Infection, other, Overactive Bladder, Voiding Dysfunction

Content Visitors (staff only)

Overactive Bladder and Neuromodulation

ICS Members Only

ICS Members Only

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

Restricted Video

Restricted Video

Session Schedule

Overactive Bladder and Neuromodulation

ICS Members Only

ICS Members Only

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

Restricted Video

Restricted Video

ICS Members Only Restricted Video

Session Schedule

Comments

Chat